FTDI
First Trust Direct Indexing’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,209
| Closed | -$312K | – | 704 |
|
|
2022
Q3 | $312K | Sell |
9,209
-464
| -5% | -$15.7K | 0.05% | 460 |
|
|
2022
Q2 | $280K | Buy |
9,673
+770
| +9% | +$22.3K | 0.04% | 490 |
|
|
2022
Q1 | $288K | Buy |
8,903
+720
| +9% | +$23.3K | 0.04% | 521 |
|
|
2021
Q4 | $239K | Hold |
8,183
| – | – | 0.03% | 556 |
|
|
2021
Q3 | $218K | Buy |
+8,183
| New | +$218K | 0.03% | 570 |
|
|
2021
Q1 | – | Sell |
-6,782
| Closed | -$171K | – | 921 |
|
|
2020
Q4 | $171K | Buy |
+6,782
| New | +$171K | 0.05% | 377 |
|